Report Library
View More
Non-Small Cell Lung Cancer (NSCLC) ...
May 9, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 7, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 6, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 3, 2024
Melanoma KOL Interview - US, Midwes...
April 30, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Datamonitor Healthcare CV&Met Disea...
April 29, 2024
Datamonitor Healthcare I&I: Axial S...
April 29, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Melanoma KOL Interview - Germany
April 26, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/11/24 | Cardurion Pharmaceuticals | CRD-740 for Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/8/24 | Teva Pharmaceutical Industries (TEVA) | TV-44749 for Schizophrenia | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/8/24 | COMPASS Pathways (CMPS) | COMP360 for Post-Traumatic Stress Disorder (PTSD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | Alvogen | Cyclurad for Bipolar Disorder | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/6/24 | EyePoint Pharmaceuticals (EYPT) | Duravyu for Diabetic Retinopathy (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/18/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |